Stock AGY ALLERGY THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Allergy Therapeutics plc

Equities

AGY

GB00B02LCQ05

Market Closed - London S.E.
Other stock markets
 11:35:23 2024-05-01 am EDT 		5-day change 1st Jan Change
2.875 GBX -0.86% Intraday chart for Allergy Therapeutics plc +2.68% +15.00%
Apr. 03 Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director CI
Mar. 27 Allergy Therapeutics Gets OK to Draw Down GBP15 Million From Amended Loan Facility MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director
CI
EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line
AN
Allergy Therapeutics plc Announces Appointment of Shaun Furlong to Board of Directors
CI
Alliance Pharma appoints chair; FireAngel sales down
AN
Scancell's Chief Development Officer to Step Down
MT
Cohort trading ahead of expectations, record orders
AN
Allergy Therapeutics appoints new CFO; interim CFO to leave in August
AN
Allergy Therapeutics Names New CFO
MT
Allergy Therapeutics Announces Resignation of Scott Leinenweber as Non-Executive Director
CI
Allergy Therapeutics plc Announces Board Appointments
CI
Allergy Therapeutics hires interim CFO as Nick Wykeman steps down
AN
Allergy Therapeutics' CFO Resigns; Interim Successor Named
MT
Allergy Therapeutics plc Appoints Martin Hopcroft as Interim CFO
CI
Allergy Therapeutics CFO To Leave In November
MT
Allergy Therapeutics plc Announces Resignation of Nick Wykeman as Chief Financial Officer, effective from November 30, 2022
CI
Allergy Therapeutics plc Announces Resignation of Nick Wykeman to Its Board Director, Effective from November 30, 2022
CI
Allergy Therapeutics plc Appoints Cheryl Faye MacDiarmid as Non-Executive Director and Member of its Audit Committee
CI
Allergy Therapeutics plc Announces Steve Smith Step Down as Non-Executive Director
CI
Allergy Therapeutics plc Announces Appointment of Mary Tavener as Chairman of the Audit Committee
CI
Allergy Therapeutics plc to Appoint Mary Tavener as Non-Executive Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGY Stock
  4. News Allergy Therapeutics plc
  5. Insiders